Which YC batch was PostEra in?

PostEra was in Y Combinator's Winter 2020 batch (W20).

Is PostEra still active?

Y Combinator lists PostEra as active.

Where is PostEra based?

PostEra lists Boston, MA, USA as its location on YC's directory.

PostEra: YC W20 company, active

Founders

Not read from YC yet; the weekly run fills these in.

Same space

Competitors

Closest in what they build, same category.

Numerion LabsW15Artificial intelligence for drug discovery.Shared: ai-powered drug discoveryActive
b12 LabsS25Making hard molecules for Pharma and BiotechShared: ai-powered drug discoveryActive

Adjacent

Overlapping tags, a different niche.

Lavo Life SciencesW23AI for drug formulationShared: ai-powered drug discovery, machine learningInactive
Persephone BiosciencesW18We are using the gut microbiome to end cancer.Shared: ai-powered drug discovery, covid-19Active
CellChorusS21The dynamic single-cell analysis companyShared: ai-powered drug discovery, machine learningActive
Diffuse BioW23Generative AI for protein designShared: ai-powered drug discovery, machine learningActive
ShiruS19Shiru leverages ML to create proteins to feed the world sustainably.Shared: ai-powered drug discovery, machine learningActive

Also from W20 in AI

Batchmates in Winter 2020.

About PostEra

PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and led the world's largest open-science drug discovery effort; COVID Moonshot.

Boston, MA, USA